Published in Infect Immun on July 01, 1977
Polymorphonuclear cell function in the various polar types of leprosy and erythema nodosum leprosum. Infect Immun (1978) 0.90
Classification of leprosy according to immunity. A five-group system. Int J Lepr Other Mycobact Dis (1966) 22.28
Hemagglutination assay for antigen and antibody associated with viral hepatitis. Science (1970) 5.81
Prevalence of hepatitis B virus antigen as revealed by direct radioimmune assay with 125 I-antibody. J Immunol (1972) 4.25
Impaired delayed hypersensitivity in patients with lepromatous leprosy. Lancet (1966) 3.26
Occurrence of malignancy in immunodeficiency diseases. A literature review. Cancer (1971) 2.31
Association between lepromatous leprosy and Australia antigen. Lancet (1967) 1.83
Immunologic reactivity in patients with leprosy. Ann Intern Med (1969) 1.39
Australia antigen and lepromatous leprosy studies in South India and elsewhere. Int J Lepr Other Mycobact Dis (1971) 1.19
T and CR+ lymphocyte profile in leprosy and the effect of treatment. Infect Immun (1976) 1.10
The Australia antigen in Brazilian healthy persons and in leprosyand leukaemia patients. J Clin Pathol (1970) 0.84
Hepatitis-B surface antigen and antibody in Bantu patients with primary hepatocellular cancer. Br J Cancer (1976) 0.81
Altered immunity and cancer risk: a review of the problem and analysis of the cancer mortality experience of leprosy patients. J Natl Cancer Inst (1969) 0.79
Incidence of cancer in patients with leprosy. Cancer (1975) 0.79
Hepatitis associated antigen (HAA) in leprosy. Lepr Rev (1971) 0.79
Australia antigen and antibody in British patients with leprosy. J Clin Pathol (1972) 0.78
Australia antigen in Zaïre. Studies on leprosy. Ann Soc Belg Med Trop (1973) 0.78
Comparative sensitivities of radioimmunoassay, crossoverelectrophoresis, and agar gel immunodiffusion for HBAg detection. Am J Clin Pathol (1976) 0.78
Studies on the Australia antigen. I. Associations between Australia antigen and leprosy. Humangenetik (1972) 0.78
Hepatitis-associated antigen and cell-mediated immunity. Lancet (1972) 0.78
Immunodeficiency in leprosy. Birth Defects Orig Artic Ser (1975) 0.77
Australia antigen in Rhodesia. Lancet (1972) 0.77
Emergence of multiply resistant pneumococci. N Engl J Med (1978) 8.32
Detection of enteric campylobacteriosis in children. J Clin Microbiol (1979) 4.57
Generalized Yersinia enterocolitica infection. J Infect Dis (1975) 3.55
Outbreake of Marburg virus disease in Johannesburg. Br Med J (1975) 3.51
Prevention of pneumococcal pneumonia by vaccination. Trans Assoc Am Physicians (1976) 3.49
Homozygous deficiency of C3 in a patient with repeated infections. Lancet (1972) 3.04
Protective efficacy of pneumococcal polysaccharide vaccines. JAMA (1977) 2.83
Antimicrobial susceptibility testing of pneumococci. 2. Determination of optimal disc diffusion test for detection of penicillin G resistance. J Antimicrob Chemother (1980) 2.73
Antimicrobial activity of ciprofloxacin against Pseudomonas aeruginosa, Escherichia coli, and Staphylococcus aureus determined by the killing curve method: antibiotic comparisons and synergistic interactions. Antimicrob Agents Chemother (1985) 2.71
Drug resistance patterns and serogroups or serotypes of pneumococcal isolates from cerebrospinal fluid or blood, 1979-1986. J Infect Dis (1988) 2.69
Protective activity of Vi capsular polysaccharide vaccine against typhoid fever. Lancet (1987) 2.59
Antimicrobial susceptibility testing of pneumococci: determination of Kirby-Bauer breakpoints for penicillin G, erythromycin, clindamycin, tetracycline, chloramphenicol, and rifampin. Antimicrob Agents Chemother (1979) 2.32
Enterotoxin production in relation to taxonomic grouping and source of isolation of Aeromonas species. J Clin Microbiol (1984) 2.27
Resistance mechanisms of multiply resistant pneumococci: antibiotic degradation studies. Antimicrob Agents Chemother (1979) 2.17
Invasive potential of noncytotoxic enteropathogenic Escherichia coli in an in vitro Henle 407 cell model. Infect Immun (1989) 1.77
In vitro stimulation of neutrophil motility by levamisole: maintenance of cgmp levels in chemotactically stimulated levamisole-treated neutrophils. J Immunol (1976) 1.76
Production of a suppressor factor by human adherent cells treated with mycobacteria. J Immunol (1980) 1.72
Mechanism of action of Yersinia enterocolitica enterotoxin. Infect Immun (1979) 1.61
Corneal ulceration at an urban African hospital. Br J Ophthalmol (1985) 1.59
Immunogenicity, efficacy and serological correlate of protection of Salmonella typhi Vi capsular polysaccharide vaccine three years after immunization. Vaccine (1996) 1.59
Clinical and nasopharyngeal isolates of unusual multiply resistant pneumococci. Am J Dis Child (1986) 1.55
Community-acquired pneumonia due to penicillin-resistant pneumococci. N Engl J Med (1985) 1.54
A microbiological study of gastro-enteritis in Black infants. S Afr Med J (1977) 1.51
Generalized infection with Yersinia enterocolitica and the role of iron. Contrib Microbiol Immunol (1979) 1.50
Campylobacter infections in Soweto. S Afr Med J (1979) 1.49
Letter: Viruses in acute summer gastroenteritis in black infants. Lancet (1975) 1.43
The effects of cyclic AMP on leucocyte inhibitory factor (LIF) production and on the inhibition of leucocyte migration. Clin Exp Immunol (1976) 1.43
Causes and treatment of sexually acquired genital ulceration in southern Africa. S Afr Med J (1989) 1.43
Pathogenic mechanisms of a non-agglutinable Vibrio cholerae strain: demonstration of invasive and enterotoxigenic properties. Infect Immun (1977) 1.43
Chronic psychosis in Turner's syndrome. Case report and a review. Br J Psychiatry (1989) 1.42
Fecal bacteria in South African rural blacks and other population groups. Isr J Med Sci (1979) 1.42
Epidemiology of rheumatic heart disease in black shcoolchildren of Soweto, Johannesburg. Br Med J (1975) 1.39
Bacteriostatic Effect of Disinfectants in Human Serum and Citrated Plasma. Br Med J (1941) 1.39
Letter: Nitroblue tetrazolium test (NBT) in the investigation of febrile patients. S Afr Med J (1973) 1.38
Factors associated with airway colonisation and invasion due to Klebsiella spp. S Afr Med J (1993) 1.38
The recent cholera outbreak in the South African gold mining industry. A preliminary report. S Afr Med J (1974) 1.37
Accuracy of clinical diagnosis of genital ulcer disease. Sex Transm Dis (1991) 1.35
A laboratory assessment of ciprofloxacin and comparable antimicrobial agents. Eur J Clin Microbiol (1984) 1.34
Antimicrobial susceptibility of 103 strains of Haemophilus ducreyi isolated in Johannesburg. Antimicrob Agents Chemother (1982) 1.33
Yersinia enterocolitica infections in South Africa. S Afr Med J (1972) 1.31
Yersiniosis I: microbiological and clinicoepidemiological aspects of plague and non-plague Yersinia infections. Eur J Clin Microbiol Infect Dis (1999) 1.28
In vitro susceptibility and cross-resistance of South African isolates of Neisseria gonorrhoeae to 14 antimicrobial agents. Antimicrob Agents Chemother (1982) 1.26
Bacteremia caused by a lactose-fermenting, multiply resistant Salmonella typhi strain in a patient recovering from typhoid fever. J Clin Microbiol (1987) 1.21
Mycobacterial skin ulcers in Nigeria. Trans R Soc Trop Med Hyg (1967) 1.21
Neonatal septicemia and meningitis due to Aeromonas shigelloides. J Pediatr (1978) 1.21
Summer diarrhoea in African infants and children. Arch Dis Child (1980) 1.20
Carriage of penicillin resistant pneumococci. Arch Dis Child (1986) 1.20
Clostridium difficile colitis associated with the use of antineoplastic agents. Eur J Clin Microbiol (1984) 1.20
Defective neutrophil motility in children with measles. J Pediatr (1976) 1.17
Isolation of human eosinophils and their lymphocyte-like rosetting properties. Immunology (1976) 1.14
Increased activity of 16-membered lactone ring macrolides against erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae: characterization of South African isolates. J Antimicrob Chemother (1998) 1.13
In vitro antimicrobial susceptibility of viridans streptococci isolated from blood cultures. Eur J Clin Microbiol Infect Dis (1992) 1.12
Age related susceptibility to Campylobacter jejuni infection in a high prevalance population. Arch Dis Child (1983) 1.12
T and CR+ lymphocyte profile in leprosy and the effect of treatment. Infect Immun (1976) 1.10
Standardisation of the nitro-blue tetrazolium test and factors affecting its clinical application. S Afr Med J (1974) 1.10
Worldwide increase in pneumococcal antibiotic resistance. Lancet (1989) 1.08
The prevalence of antimicrobial resistance in human faecal flora in South Africa. Epidemiol Infect (1993) 1.08
Regional prevalence of hepatitis B, delta, and human immunodeficiency virus infection in southern Africa: a large population survey. Am J Epidemiol (1989) 1.08
Antibiotic-resistant pneumococci in hospitalized children. J Hyg (Lond) (1984) 1.08
The Widal test in the diagnosis of typhoid fever in the transvaal. S Afr Med J (1981) 1.07
Etiology of infantile enteritis in South Africa. Isr J Med Sci (1979) 1.07
Serum immunoglobulin levels in primary liver cancer: relationship to underlying cirrhosis and hepatitis-B (surface) antigenaemia. Br J Cancer (1975) 1.05
In vitro activity of A-56619 (difloxacin), A-56620, and other new quinolone antimicrobial agents against genital pathogens. Antimicrob Agents Chemother (1986) 1.05
In vitro selection of bacteria resistant to LY146032, a new cyclic lipopeptide. Antimicrob Agents Chemother (1988) 1.03
Antimicrobial susceptibility of Haemophilus ducreyi. Antimicrob Agents Chemother (1990) 1.03
Production of leucocyte inhibitory factor (LIF) and macrophage inhibitory factor (MIF) by PHA-stimulated lymphocytes. Clin Exp Immunol (1975) 1.02
Comparison of bacteraemic community-acquired lobar pneumonia due to Streptococcus pneumoniae and Klebsiella pneumoniae in an intensive care unit. Respiration (1991) 1.01
Community-acquired pneumonia of diverse aetiology: prognostic features in patients admitted to an intensive care unit and a "severity of illness" core. Intensive Care Med (1989) 1.01
Intra- and inter-specific transformation of Streptococcus pneumoniae to penicillin resistance. J Antimicrob Chemother (1990) 1.00
A simple medium for the primary isolation of Haemophilus ducreyi. Eur J Clin Microbiol Infect Dis (1992) 1.00
Wound colonization by Ewingella americana. J Clin Microbiol (1986) 1.00
Sugar-substituted 2-azetidinones as cholesterol absorption inhibitors. Bioorg Med Chem Lett (1998) 0.99
Hepatosplenic abscesses due to Yersinia enterocolitica. Br Med J (1972) 0.99
Enhancement of haemolytic activity of asbestos by heat-labile factors in fresh serum. Med Lav (1971) 0.98
Leucocyte capillary migration: an adherence dependent phenomenon. Clin Exp Immunol (1976) 0.98
Meningitis in a community with a high prevalence of tuberculosis and HIV infection. J Neurol Sci (1999) 0.98
Long-term infections with Campylobacter fetus subsp. jejuni. J Clin Microbiol (1981) 0.97
The risk of infection from Giardia lamblia due to drinking water supply, use of water, and latrines among preschool children in rural Lesotho. Int J Epidemiol (1989) 0.97
Plasmid-mediated NAD independence in Haemophilus parainfluenzae. J Gen Microbiol (1991) 0.97
Salmonellae and Shigellae in Bantu children consuming drinking water of improved quality. S Afr Med J (1968) 0.96
Identification of a novel plasmid-encoded dihydrofolate reductase mediating high-level resistance to trimethoprim. J Antimicrob Chemother (1988) 0.95
Antimicrobial susceptibilities of southern African isolates of Haemophilus ducreyi. Antimicrob Agents Chemother (1988) 0.95
Seroepidemiology of human immunodeficiency virus in Africa from 1970 to 1974. N Engl J Med (1987) 0.95
Emergence of a pneumococcal clone with cephalosporin resistance and penicillin susceptibility. Antimicrob Agents Chemother (2001) 0.94
Enteric fever caused by Salmonella paratyphi C in South and South West Africa. S Afr Med J (1978) 0.94
Penicillin-binding proteins of Streptococcus pneumoniae. J Antimicrob Chemother (1988) 0.93
A serological test for granuloma inguinale. Genitourin Med (1992) 0.93
Bacterial meningitis in Johannesburg--1980-1982. S Afr Med J (1984) 0.93
Comparison of preservation media and freezing conditions for storage of specimens of faeces. J Med Microbiol (1989) 0.92
Screening for cytomegalovirus retinitis at an AIDS clinic. S Afr Med J (2002) 0.92
Klebsiella pneumoniae bacteraemia at an urban general hospital. J Infect (1990) 0.91
Laboratory surveillance of synergy between and resistance to trimethoprim and sulfonamides. Rev Infect Dis (1982) 0.91
In vitro reversal of cellular unresponsiveness induced by levamisole. Clin Exp Immunol (1976) 0.91
Nucleotide sequence of dihydrofolate reductase type VI. J Med Microbiol (1991) 0.91